Nothing Special   »   [go: up one dir, main page]

GB201521542D0 - Methods for the treatment of cardiovascular disorders - Google Patents

Methods for the treatment of cardiovascular disorders

Info

Publication number
GB201521542D0
GB201521542D0 GBGB1521542.9A GB201521542A GB201521542D0 GB 201521542 D0 GB201521542 D0 GB 201521542D0 GB 201521542 A GB201521542 A GB 201521542A GB 201521542 D0 GB201521542 D0 GB 201521542D0
Authority
GB
United Kingdom
Prior art keywords
treatment
methods
cardiovascular disorders
cardiovascular
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1521542.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galapagos NV
Original Assignee
Galapagos N V And Abbvie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galapagos N V And Abbvie Inc filed Critical Galapagos N V And Abbvie Inc
Priority to GBGB1521542.9A priority Critical patent/GB201521542D0/en
Publication of GB201521542D0 publication Critical patent/GB201521542D0/en
Priority to MX2017013103A priority patent/MX2017013103A/en
Priority to HUE16712378A priority patent/HUE063820T2/en
Priority to EP16712378.5A priority patent/EP3283114B1/en
Priority to US15/566,002 priority patent/US10376520B2/en
Priority to CA2982629A priority patent/CA2982629C/en
Priority to ES16712378T priority patent/ES2959612T3/en
Priority to PL16712378.5T priority patent/PL3283114T3/en
Priority to RS20230922A priority patent/RS64677B1/en
Priority to EA201792265A priority patent/EA037911B1/en
Priority to BR112017021589-6A priority patent/BR112017021589B1/en
Priority to PCT/EP2016/057103 priority patent/WO2016165952A1/en
Priority to AU2016248727A priority patent/AU2016248727B2/en
Priority to HRP20231192TT priority patent/HRP20231192T1/en
Priority to CN201680021723.7A priority patent/CN107438609B/en
Priority to JP2017553315A priority patent/JP6898249B2/en
Priority to NZ735883A priority patent/NZ735883B2/en
Priority to KR1020177032860A priority patent/KR20170134751A/en
Priority to SG11201708198SA priority patent/SG11201708198SA/en
Priority to HK18109990.1A priority patent/HK1250624A1/en
Ceased legal-status Critical Current

Links

GBGB1521542.9A 2015-04-13 2015-12-07 Methods for the treatment of cardiovascular disorders Ceased GB201521542D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GBGB1521542.9A GB201521542D0 (en) 2015-12-07 2015-12-07 Methods for the treatment of cardiovascular disorders
SG11201708198SA SG11201708198SA (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
RS20230922A RS64677B1 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
BR112017021589-6A BR112017021589B1 (en) 2015-04-13 2016-03-31 USE OF COMPOUNDS THAT INHIBIT JAK1 FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS AND/OR DRUGS FOR THE TREATMENT OF ATHEROSCLEROSIS AND/OR DYSLIPIDEMIA
EP16712378.5A EP3283114B1 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
US15/566,002 US10376520B2 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
CA2982629A CA2982629C (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
ES16712378T ES2959612T3 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
PL16712378.5T PL3283114T3 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
MX2017013103A MX2017013103A (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders.
EA201792265A EA037911B1 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
HUE16712378A HUE063820T2 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
PCT/EP2016/057103 WO2016165952A1 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
AU2016248727A AU2016248727B2 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
HRP20231192TT HRP20231192T1 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
CN201680021723.7A CN107438609B (en) 2015-04-13 2016-03-31 Methods for treating cardiovascular disorders
JP2017553315A JP6898249B2 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
NZ735883A NZ735883B2 (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
KR1020177032860A KR20170134751A (en) 2015-04-13 2016-03-31 Methods for the treatment of cardiovascular disorders
HK18109990.1A HK1250624A1 (en) 2015-04-13 2018-08-02 Methods for the treatment of cardiovascular disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1521542.9A GB201521542D0 (en) 2015-12-07 2015-12-07 Methods for the treatment of cardiovascular disorders

Publications (1)

Publication Number Publication Date
GB201521542D0 true GB201521542D0 (en) 2016-01-20

Family

ID=55234517

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1521542.9A Ceased GB201521542D0 (en) 2015-04-13 2015-12-07 Methods for the treatment of cardiovascular disorders

Country Status (1)

Country Link
GB (1) GB201521542D0 (en)

Similar Documents

Publication Publication Date Title
IL285151B1 (en) Methods of treating fgf21-associated disorders
HK1259458A1 (en) Gemcabene combinations for the treatment of cardiovascular disease
IL279627A (en) Method for the treatment of depression
IL279308A (en) Methods for treating hepcidin-mediated disorders
HK1252996A1 (en) Methods for the treatment of epilepsy
HK1232220A1 (en) Derivatives of 5-benzylisoquinoline for the treatment of cardiovascular diseases 5-
SG11201708181RA (en) Methods for the treatment of inflammatory disorders
HK1247558A1 (en) Cenicriviroc for the treatment of fibrosis
SG11201609522TA (en) Methods for treating cardiovascular diseases
PL3484475T3 (en) 1-methylnicotinamide for the treatment of cardiovascular disease
GB201607388D0 (en) Treatment of impulsivity-related disorders
HK1250624A1 (en) Methods for the treatment of cardiovascular disorders
GB201521542D0 (en) Methods for the treatment of cardiovascular disorders
GB201513991D0 (en) Methods for the treatment of cardiovascular disorders
GB201513344D0 (en) Methods for the treatment of Cardiovascular disorders
GB201507109D0 (en) Methods for the treatment of cardiovascular disorders
GB201521543D0 (en) Methods for the treatment of inflammatory disorders
GB201506228D0 (en) Methods For The Treatment Of Cardivascular Disorders
GB201513993D0 (en) Methods for the treatment of inflammatory disorders
GB201513345D0 (en) Methods for the treatment of Inflammatory disorders
GB201507113D0 (en) Methods for the treatment of inflammatory disorders
GB201506419D0 (en) Methods for the treatment of inflammatory disorders
GB201506229D0 (en) Methods For the Treatment Of Inflammatory Disorders
GB201602784D0 (en) New treatment of CFTR-related disorders
GB201516418D0 (en) Treatment of acute inflammatory disorders

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: GALAPAGOS NV

Free format text: FORMER OWNERS: ABBVIE INC;GALAPAGOS N.V.

AT Applications terminated before publication under section 16(1)